Your browser doesn't support javascript.
loading
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
Huang, Yunda; Borisov, Oleg; Kee, Jia Jin; Carpp, Lindsay N; Wrin, Terri; Cai, Suqin; Sarzotti-Kelsoe, Marcella; McDanal, Charlene; Eaton, Amanda; Pajon, Rolando; Hural, John; Posavad, Christine M; Gill, Katherine; Karuna, Shelly; Corey, Lawrence; McElrath, M Juliana; Gilbert, Peter B; Petropoulos, Christos J; Montefiori, David C.
Afiliação
  • Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. yunda@scharp.org.
  • Borisov O; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. yunda@scharp.org.
  • Kee JJ; Department of Global Health, University of Washington, Seattle, WA, USA. yunda@scharp.org.
  • Carpp LN; Biomedical Advanced Research and Development Authority, Washington, DC, USA.
  • Wrin T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Cai S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Sarzotti-Kelsoe M; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
  • McDanal C; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
  • Eaton A; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Pajon R; Department of Immunology, Duke University Medical Center, Durham, NC, USA.
  • Hural J; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Posavad CM; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Gill K; Moderna, Inc., Cambridge, MA, USA.
  • Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • McElrath MJ; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Petropoulos CJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Montefiori DC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Sci Rep ; 11(1): 23921, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34907214
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Testes de Neutralização / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Testes de Neutralização / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos